Adeno-associated virus-mediated delivery of GDNF to skeletal...

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S04400A, C435S320100, C435S455000, C435S456000

Reexamination Certificate

active

07112321

ABSTRACT:
Compositions and methods for delivering GDNF to skeletal muscles to result in a therapeutic effect are disclosed. The compositions and methods use adeno-associated virus (AAV)-based gene delivery systems. The methods are useful for treating motoneuron diseases, such as amyotrophic lateral sclerosis (ALS).

REFERENCES:
patent: 5858351 (1999-01-01), Podsakoff et al.
patent: 5858775 (1999-01-01), Johnson
patent: 6180613 (2001-01-01), Kaplitt et al.
patent: 6325998 (2001-12-01), Podsakoff et al.
patent: 6552003 (2003-04-01), Finiels et al.
Martinov et al., “Selective targeting of subpopulations of nerve and muscle cells in vivo by recombinant viral vectors,” Soc. Neurosci. Abstr. 27(2): 2478, Nov. 2001.
Acsadi et al., “GDNF gene therapy by adeno- and adeno-associated virus vectors improves the survival and motor functions of ALS (SOD1) mice,”J. Neurological Sciences1 (Suppl. 1):S34, 2002.
Alisky et al., “Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases,”Human Gene Therapy11:2315-2329, 2000.
Baumgartner et al., “Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line-derived neurotrophic factor,”J. Neurosci. Res. 54:766-777, 1998.
Blesch et al., “GDNF gene delivery to injured adults CNS motor neurons promotes axonal growth, expression of the trophic neuropeptide CGRP, and cellular protection,”J. Comp. Neurol. 436:399-410, 2001.
Blits et al., “AAV-mediated overexpression of GDNF and BDNF rescues motorneurons following avulsion and reimplantation of rat lumbar ventral roots,” abstract,Society for Neuroscience27(2):2116, 2001.
Bohn, “A commentary on glial cell lin-derived neurotrophic factor (GDFN),”Biochem. Pharmacol. 57:135-142, 1999.
Büeler, “Adeno-associated viral vectors for gene transfer and gene therapy,”Biol. Chem. 380:613-622, 1999.
Haase et al., “Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors,”Nat. Med. 3:429-436, 1997.
Henderson et al., “GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle,”Science266:1062-1064, 1994.
Kay et al., “Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector,”Nat. Genet. 24:257-261, 2000.
Keir et al., “Adeno-associated virus-mediated delivery of glial cell line-derived neuotrophic factor protects motor neuron-like cells from apoptosis,”J. NeuroVirology7:437-446, 2001.
Keller-Peck et al., “Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction,”J. Neurosci. 21:6136-6146, 2001.
Lie et al., “GDNF expression is increased in denervated human skeletal muscle,”Neurosci. Lett. 250:87-90, 1998.
Mandel et al., “Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats,”Proc. Natl. Acad. Sci. USA94:14083-14088, 1997.
Mohajeri et al., “Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis,”Hum. Gene Ther. 10:1853-1866, 1999.
Oppenheim et al., “Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF,”Nature373:344-346, 1995.
Sagot et al., “GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice,”J. Neurosci. 16:2335-2341, 1996.
Sagot et al., “Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease,”J. Neurosci. 18:1132-1141, 1998.
Trupp et al., “Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons,”J. Cell Biol. 130:137-148, 1995.
Wang et al., “Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model,”Proc. Natl. Acad. Sci. USA97:13714-13719, 2000.
Wang et l., “Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic laternal sclerosis,” J. Neuroscience 22(16):6920-6928, 2002.
Xiao et al., “Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector,”J. Virol. 70:8098-8108, 1996.
Yamamoto et al., “Expression of GDNF and GDNFR-α mRNAs in muscles of patients with motor neuron diseases,”Neurochem. Res. 24:785-790, 1999.
Yan et al., “In vivo neutrophic effects of GDNF on neonatal and adult facial motor neurons,”Nature373:341-344, 1995.
Yuen, “The role of neurotrophic factors in disorders of peripheral nerves and motor neurons,”Phys. Med. Rehabil. Clin. N. Am. 12:293-306, 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Adeno-associated virus-mediated delivery of GDNF to skeletal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adeno-associated virus-mediated delivery of GDNF to skeletal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus-mediated delivery of GDNF to skeletal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3617587

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.